Orexigen Therapeutics (OREX) Pops on Positive Arena (ARNA) Comments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Join SI Premium – FREE
Orexigen Therapeutics (Nasdaq: OREX) is out of the gate higher Monday following some positive comments by firm Jefferies on Orexigen peer Arena Pharma (Nasdaq: ARNA).
Shares are 7.6 percent better in early trade.
For more on the comments, click here.
Shares are 7.6 percent better in early trade.
For more on the comments, click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lumentum's optical components sold out through early 2029: CEO
- Musk rules out TSMC role in Terafab operations; Intel gains
- Jefferies Downgrades ONE Gas Inc. (OGS) to Hold
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
